Work

Table S1 from Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer

Year: 2023

Type: other

Abstract: Table S1. List of phosphopeptides identified by phosphoproteomics experiments in A427 and A549 cell line treated with vehicle control (DMSO) or MEK inhibitor (selumetinib)

DOI: 10.1158/1541-7786.22514103

Authors: Jae-Young Kim, Eric A. Welsh, Bin Fang, Yun Bai, Fumi Kinose, Steven A. Eschrich, John M. Koomen, Eric B. Haura

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362613231

Cites:

Cited by:

Related to: 10